11 th European Functional Drug Screening Symposium FDSS Users - PowerPoint PPT Presentation

May 29, 2023 •278 likes •435 views

11 th European Functional Drug Screening Symposium FDSS Users Meeting June 11th, 2015 at Axiogenesis AG in Cologne, Germany (BioCampus) Hamamatsu Photonics solutions for drug discovery life sciences Thomas Niedereichholz 2015 Hamamatsu 2

11 th European Functional Drug Screening Symposium FDSS Users Meeting June 11th, 2015 at Axiogenesis AG in Cologne, Germany (BioCampus) Hamamatsu Photonics solutions for drug discovery – life sciences Thomas Niedereichholz 2015
Hamamatsu 2
Hamamatsu Europe 3
Hamamatsu Photonics - Japan ETD 4
Hamamatsu Photonics - Japan SSD 5
Hamamatsu Photonics - Japan SYS 6
Hamamatsu – Life Photonics 7
Hamamatsu - The Living Image 8
Seeing the Living Brain Ahrens, M. B., Orger, M. B., Robson, D. N., Li, J. M. & Keller, P. J. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. 9 Nat. Methods (2013) 10, 413 – 420. PMID: 23524393.
Seeing the Living Brain Dorsal and lateral projections of whole-brain, neuron-level functional activity, reported by the genetically encoded calcium indicator GCaMP5G in an elavl3:GCaMP5G fish via changes in fluorescence intensity ( Δ F/F), superimposed on the reference anatomy. Video courtesy of Philipp Keller, Lab Head, Janelia Farm Research Campus. Ahrens, M. B., Orger, M. B., Robson, D. N., Li, J. M. & Keller, P. J. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. 10 Nat. Methods (2013) 10, 413 – 420. PMID: 23524393.
Nanozoomer – Whole Slide Imaging 11
Functional Drug Screening Solutions 12
Functional Drug Screening Solutions Your needs? 13
www.fdssdrug.com 14

Recommend

Outlines Drug discovery HTS Screening Computational Screening Structure-based

Modeling HTS Screening for Drug discovery Ying-Ta Wu Genomics Research Center, Academia Sinica, Taiwan. e-mail: ywu@gate.sinica.edu.tw Outlines Drug discovery HTS Screening Computational Screening Structure-based approach

803 views • 37 slides

Chemspace Phenotypic Screening Set Description Phenotypic screening (PS) is one of the two major

Chemspace Phenotypic Screening Set Description Phenotypic screening (PS) is one of the two major approaches at early stage drug discovery projects, apart from the target-based screens. PS is focused on the overall effect a drug molecule causes

337 views • 6 slides

Drug screening against Yellow fever Virus Lucio Freitas Junior Departamento de

Drug screening against Yellow fever Virus Lucio Freitas Junior Departamento de Micorbiologia Instituto de Cincias Biomdicas Universidade de So Paulo The Phenotypic Screening Platform at ICB-USP Chemical and Genetic screening

289 views • 18 slides

Analysis of High Throughput FDSS Kinetic Data Jrg Fischer, Ingo Khlborn, Martin Adamczewski

Analysis of High Throughput FDSS Kinetic Data Jrg Fischer, Ingo Khlborn, Martin Adamczewski Bayer CropScience AG BCS-R&D-SMR-RT FDSS use in HTS HTS: >10 000 to >100 000 tests/day single compound, single concentration,

276 views • 8 slides

Urinary antihypertensive drug metabolite screening using molecular networking coupled to

Urinary antihypertensive drug metabolite screening using molecular networking coupled to high-resolution mass spectrometry fragmentation Justin J. J. van der Hooft Sandosh Padmanabhan Karl E. V. Burgess Michael P. Barrett (2016).

492 views • 16 slides

Drug Development Jeremy M. Berg Fifth Annual Ri.MED Scientific Symposium October 24, 2011 The

The Shape of Things to Come: Structural Biology and Drug Development Jeremy M. Berg Fifth Annual Ri.MED Scientific Symposium October 24, 2011 The Promise of Structure- Based Drug Design Knowledge of the 3-D structure of a drug target should

472 views • 34 slides

Barriers and Facilitators to screening and treatment for Hepatitis C among Injecting Drug Users in

Barriers and Facilitators to screening and treatment for Hepatitis C among Injecting Drug Users in Georgia April, 2017 www.curatiofoundation.org Who did the study Research team CIF: Ivdity Chikovani, Natia Shengelia, Lela Sulaberidze,

395 views • 28 slides

You Cant Fool the Bladder Police Effective Use of Urine Drug Screening Wh Why Te Test?

You Cant Fool the Bladder Police Effective Use of Urine Drug Screening Wh Why Te Test? Accountability Create and maintain safe treatment environment Compliance with licensing or policy Collection Supervised or

489 views • 37 slides

1 2 3 4 5 F I N A N C I A L P R O T E C T I O N S S E R V I C E SCREENING The Screening

SCREENING GUIDE 1 2 3 4 5 F I N A N C I A L P R O T E C T I O N S S E R V I C E SCREENING The Screening Guide is based on a Scoping Study, which determined the Screening Tools and other relevant matters. See Chapter 1 for a summary of

480 views • 20 slides

Importance of calcium assay parameters in drug discovery Sabine Rouanet Dr. Isabelle Bertrand

Actelion Pharmaceutical Allschwill Hamamatsu 10th FDSS User Meeting June 2014 Importance of calcium assay parameters in drug discovery Sabine Rouanet Dr. Isabelle Bertrand Dr. Stphane Krief Directeur: Dr. Thierry Calmels Pr. Jean-Charles

994 views • 31 slides

Exploring muscle mass measurements that predict functional outcomes Gulistan Bahat, MD Istanbul

SIG Symposium IMPROVING PREVENTIVE SCREENING FOR SARCOPENIA Exploring muscle mass measurements that predict functional outcomes Gulistan Bahat, MD Istanbul Medical School Division of Geriatrics EUGMS Congress 2017-Nice, September 21 CONFLICT

1.29k views • 100 slides

Screening, Brief Intervention, and Referral to Treatment (SBIRT): An approach to alcohol and drug

Screening, Brief Intervention, and Referral to Treatment (SBIRT): An approach to alcohol and drug use prevention for high school students in Southeastern Wisconsin TRIUMPH Intern Presentation Senait Tesfai-Barker, M4 May 2013 W HAT IS SBIRT?

432 views • 18 slides

On-Site Drug Screening An industry perspective IVD Australia Inc An ASIC registered

On-Site Drug Screening An industry perspective IVD Australia Inc An ASIC registered incorporated company with a board of directors a CEO operating with a constitution & Code of Conduct Industry Peak body representing >50 companies

611 views • 6 slides

Screening System Hardware and Software Integration 11. June 2015, Jrg Fischer, V1.0 Bayer

Integration of FDSS 7000 into Beckman HTS Screening System Hardware and Software Integration 11. June 2015, Jrg Fischer, V1.0 Bayer CropScience Research Campus in Monheim Hamamatsu User Meeting 2015 Bayer CropScience AG, Jrg

286 views • 13 slides

Colonoscopy Screening: Issues and Controversies Symposium on GI Cancers St. Louis 9-12-09

Colonoscopy Screening: Issues and Controversies Symposium on GI Cancers St. Louis 9-12-09 David Lieberman MD Chief, Division of Gastroenterology and Hepatology Oregon Health Sciences University Portland VAMC Risk Factors for CRC HNPCC

746 views • 29 slides

HOW TO FIND THE RIGHT TREATMENT, AT THE RIGHT TIME: MICROFLUIDICS CAN HELP! Prof. Gabriele Dubini

HOW TO FIND THE RIGHT TREATMENT, AT THE RIGHT TIME: MICROFLUIDICS CAN HELP! Prof. Gabriele Dubini | Politecnico di Milano MASTERCLASS SERIES 2020 VIRTUAL EXPERIENCE DRUG SCREENING Drug screening is the process by which potential drugs are

622 views • 24 slides

Comprehensive in vitro Proarrhythmia Assay (CiPA) Using Cor.4U Cardiomyocytes with the FDSS in a

Company Cooperation Products &Services Marketing Financials Comprehensive in vitro Proarrhythmia Assay (CiPA) Using Cor.4U Cardiomyocytes with the FDSS in a Calcium Transient Assay 09.06.2016 Hamamatsu User Meeting Dr. Ralf Kettenhofen

561 views • 35 slides

Challenges in Gynecologic Cancer Screening 8 th Asian Health Symposium Lee-may Chen, MD

Disclosure UCSF Helen Diller Family Comprehensive Cancer Center I have no relevant financial relationships with any companies related to the content of this course. Challenges in Gynecologic Cancer Screening 8 th Asian Health Symposium

517 views • 8 slides

10/12/2018 Employed by ECDC European evidencebased guidance on screening No conflicts to

10/12/2018 Employed by ECDC European evidencebased guidance on screening No conflicts to disclose for infectious diseases among newly arrived migrants Teymur Noori European Centre for Disease Prevention and Control (ECDC) International

308 views • 5 slides

QUAPO : Quantitative Analysis of Pooling in High-Throughput Drug Screening Raghu Kainkaryam

QUAPO : Quantitative Analysis of Pooling in High-Throughput Drug Screening Raghu Kainkaryam Systems Biology Group University of Michigan (joint work with Anna Gilbert, Paul Shearer and Peter Woolf) March 27, 2009 DIMACS/DyDAn Workshop on

442 views • 26 slides

Mistakes and Opportunities in Screening and Drug Testing Presented by: James P. Randisi

Mistakes and Opportunities in Screening and Drug Testing Presented by: James P. Randisi www.randisiandassociates.com info@randisiandassociates.com Phone: 410.494.0232 1 Overview Build Awareness of Mistakes Other Organizations Have Made in

666 views • 18 slides

Fuzzy Logic Interval Clustering for Drug Discovery PREDICTION ACCURACY FOR DRUG DISCOVERY

Fuzzy Logic Interval Clustering for Drug Discovery PREDICTION ACCURACY FOR DRUG DISCOVERY PROBLEM Hundreds of Test EACH thousands of compoundon High throughput screening compoundsare the desired (HTS) is expensive and time-

554 views • 5 slides

Colorectal Cancer Screening Optimizing Mortality Reductions Agenda through Colorectal Cancer

Colorectal Cancer Screening Optimizing Mortality Reductions Agenda through Colorectal Cancer Screening Which test is best? Asian Health Symposium San Francisco. October 2017 How to increase screening among Asians? How do you prepare

266 views • 13 slides

in Drug Discovery (AMIDD) How were new medicines discovered? Yao, Peter, Petra, Carlos, Jan

Introduction to Applied Mathematics and Informatics in Drug Discovery (AMIDD) How were new medicines discovered? Yao, Peter, Petra, Carlos, Jan Content 1. Target-based screening 2. Phenotypic based screening 3. Examples of discovered

541 views • 30 slides